222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details

臨床試験数 : 310 / 薬物数 : 295 - (DrugBank : 117) / 標的遺伝子数 : 63 - 標的パスウェイ数 : 194

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02592798 (ClinicalTrials.gov)	March 1, 2016	29/10/2015	Pilot Study to Evaluate the Safety and Efficacy of Abataceptin Adults and Children 6 Years and Older ...	A Phase II Randomized, Placebo-Controlled, Double-Blind, Parallel Arms, Pilot Study to Evaluate the ...	Nephrotic Syndrome;Focal Segmental Glomerulosclerosis;Minimal Change Disease	Drug: Abatacept;Other: Normal Saline;Other: D5W	Bristol-Myers Squibb	NULL	Completed	6 Years	N/A	All	36	Phase 2	United States
2	EUCTR2015-005450-36-Outside-EU/EEA (EUCTR)		01/08/2016	Pilot to Evaluate the Safety and Efficacy of Abataceptin Adults and Children Over the Age of 6 With ...	A Phase II Randomized, Placebo-Controlled, Double-Blind, Parallel Arms With Switchover, Pilot Study ...	Rheumatoid Arthritis MedDRA version: 19.0;Level: PT;Classification code 10039073;Term: Rheumatoid ar ...	Trade Name: Orencia Product Name: Abatacept Product Code: BMS-188667 INN or Proposed INN: ABATACEPT	Bristol-Myers Squibb Company	NULL	NA			Female: yes Male: yes	100	Phase 2	United States

First Previous1Next Last